Pharma & Healthcare Market Research Report

Report Filter Reset All

Sort By Price

Published Date

Category

Clear All

Publishers

Clear All

Report Type

Continents

Clear All

Regions

Clear All

Countries

Clear All

Pharma & Healthcare

Complement 3 Glomerulopathy (C3G) - Market Insights, Epidemiology and Market Forecast– 2030

DelveInsight’s ‘Complement 3 Glomerulopathy (C3G) - Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding of the...

$6,950.00 07 September, 2020 | DelveInsight

DelveInsight’s ‘Complement 3 Glomerulopathy (C3G) - Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understand...

Pharma & Healthcare

Cutaneous T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast - 2030

DelveInsight’s ‘Cutaneous T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast - 2030’ report, delivers an in-depth understanding of the diseas...

$6,950.00 07 September, 2020 | DelveInsight

DelveInsight’s ‘Cutaneous T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast - 2030’ report, delivers an in-depth understanding of ...

Pharma & Healthcare

Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast – 2030

DelveInsight’s ‘Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast – 2030’ report deliver an in-depth understanding of the disease, histo...

$6,950.00 07 September, 2020 | DelveInsight

DelveInsight’s ‘Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast – 2030’ report deliver an in-depth understanding of the dise...

Pharma & Healthcare

Gastroparesis—Market Insights, Epidemiology and Market Forecast–2030

DelveInsight’s ‘Gastroparesis—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the Gastroparesis, histori...

$6,950.00 07 September, 2020 | DelveInsight

DelveInsight’s ‘Gastroparesis—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the Gastroparesi...

Pharma & Healthcare

Glioblastoma Multiforme (GBM) - Market Insights, Epidemiology and Market Forecast– 2030

DelveInsight’s ‘Glioblastoma Multiforme (GBM) - Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding of the Gli...

$6,950.00 07 September, 2020 | DelveInsight

DelveInsight’s ‘Glioblastoma Multiforme (GBM) - Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding ...

Pharma & Healthcare

Hereditary Transthyretin Amyloidosis (hATTR)- Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2030

DelveInsight’s ‘Hereditary Transthyretin Amyloidosis (hATTR)- Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2030’ report delivers ...

$6,950.00 07 September, 2020 | DelveInsight

DelveInsight’s ‘Hereditary Transthyretin Amyloidosis (hATTR)- Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2030’ report...

Pharma & Healthcare

Hypofibrinogenemia - Market Insights, Epidemiology, and Market Forecast - 2030

DelveInsight’s ‘Hypofibrinogenemia – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the Hypofibrinogene...

$6,950.00 07 September, 2020 | DelveInsight

DelveInsight’s ‘Hypofibrinogenemia – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the Hypof...

Pharma & Healthcare

Multiple Myeloma - Market Insights, Epidemiology and Market Forecast - 2030

DelveInsight’s ‘Multiple Myeloma (MM)-Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the MM, historical...

$11,900.00 07 September, 2020 | DelveInsight

DelveInsight’s ‘Multiple Myeloma (MM)-Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the MM, ...

Pharma & Healthcare

Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030

DelveInsight’s ‘Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding ...

$6,950.00 07 September, 2020 | DelveInsight

DelveInsight’s ‘Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth unde...

Pharma & Healthcare

Pemphigus Vulgaris (PV)-Market Insights, Epidemiology, and Market Forecast–2030

DelveInsight’s ‘Pemphigus Vulgaris (PV)-Market Insights, Epidemiology, and Market Forecast–2030’ report deliver an in-depth understanding of the PV, historic...

$6,950.00 07 September, 2020 | DelveInsight

DelveInsight’s ‘Pemphigus Vulgaris (PV)-Market Insights, Epidemiology, and Market Forecast–2030’ report deliver an in-depth understanding of the PV...